Stemregen® Names Ryan Riley As Chief Executive Officer, Christian Drapeau As Chief Science Officer
Apr 25, 2024•over 1 year ago
Position
Chief Science Officer
Company
STEMREGEN®
Description
STEMREGEN® announces leadership team changes aligned around the company's business objectives and growth trajectory. Christian Drapeau, the neurophysiology scientist and founder, will become Chief Science Officer to focus on the brand's cutting-edge stem cell research. Ryan Riley, former CEO of Microbe Formulas and CellCore Biosciences, will succeed Drapeau as CEO.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months